🔗 Permalink

Assignee profile:

Exela Pharma Sciences, LLC

City:

Lenoir, North Carolina

Country:

United States

Published Applications:

Last publication date:

2026-03-10

Patent Grants:

Last grant date:

2026-03-10

Top Inventors for applications by Exela Pharma Sciences, LLC

These are the the leading inventors for applications assigned to Exela Pharma Sciences, LLC:

Aruna Koganti 17 Lenoir, NC United States
Phanesh Koneru 17 Waxhaw, NC United States
John Maloney 17 Salisbury, NC United States
Sreerama Murthy Mallipeddi 2 Hickory, NC United States

Jonathan E. Sterling 2 Morganton, NC United States
Phanesh B. Koneru 2 Ashburn, VA United States

Recent patent applications by Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC based in Lenoir, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-10 ✅ Patent 12,569,514 granted on 2026-03-10

US19011111

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#2 | 2026-03-10 ✅ Patent 12,569,513 granted on 2026-03-10

US19001318

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#3 | 2025-01-07 ✅ Patent 12,186,338 granted on 2025-01-07

US18651036

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#4 | 2024-12-24 ✅ Patent 12,171,781 granted on 2024-12-24

US18651026

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#5 | 2024-06-06

US20240181064A1

Human necessities

GANCICLOVIR COMPOSITIONS AND RELATED METHODS

#6 | 2024-04-30 ✅ Patent 11,969,439 granted on 2024-04-30

US18520172

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#7 | 2023-11-28 ✅ Patent 11,826,383 granted on 2023-11-28

US18332677

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#8 | 2023-06-27 ✅ Patent 11,684,636 granted on 2023-06-27

US17950979

Human necessities

Stable, highly pure l-cysteine compositions for injection and methods of use

#9 | 2023-06-20 ✅ Patent 11,679,125 granted on 2023-06-20

US18067605

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#10 | 2023-06-13 ✅ Patent 11,672,824 granted on 2023-06-13

US17950964

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#11 | 2023-05-16 ✅ Patent 11,648,262 granted on 2023-05-16

US18067397

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#12 | 2023-05-09 ✅ Patent 11,642,370 granted on 2023-05-09

US18067287

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#13 | 2022-11-29 ✅ Patent 11,510,942 granted on 2022-11-29

US17188922

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#14 | 2022-11-29 ✅ Patent 11,510,941 granted on 2022-11-29

US17164263

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#15 | 2020-10-08 ✅ Patent 11,723,978 granted on 2023-08-15

US20200316075A1

Human necessities

Ganciclovir compositions and related methods

#16 | 2020-07-16 ✅ Patent 10,905,713 granted on 2021-02-02

US20200222448A1

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#17 | 2020-05-19 ✅ Patent 10,653,719 granted on 2020-05-19

US16773563

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#18 | 2020-03-10 ✅ Patent 10,583,155 granted on 2020-03-10

US16665702

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

#19 | 2019-11-19 ✅ Patent 10,478,453 granted on 2019-11-19

US16248460

Human necessities

Stable, highly pure L-cysteine compositions for injection and methods of use

Also check out Exela Pharma Sciences, LLC's (Lenoir, United States) applicant profile with 21 patent applications submitted.

AssigneeID:

163816 ⎘